AKTS
Aktis Oncology, Inc.
Next earnings ≈ Aug 3, 2026 · est. from filing cadence
Last earnings -1.8% on 2026-05-11
$31.15
▲ +8.54%$31.15▲ +39.06%
over 1Y
L $15.19EODHDH $31.15
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+8.5%
1W+29.3%
1M+51.4%
3M+76.8%
YTD+39.1%
1Y+39.1%
Sell
Conviction
Horizon
Medium (3–12mo)
Street · 12 analysts
Strong Buy
Mixed signals in the latest filings.
Aktis Oncology, Inc. shows limited reported revenue.
Sources: SEC EDGAR (CIK 0002035832, latest 10-Q filed 2026-05-11) · EODHD · as of 6/26/2026, 1:58:07 AM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.